BRIEF-Alnylam Pharmaceuticals names David-Alexandre Gros Principal Financial Officer By: Reuters: Company News June 15, 2016 at 16:45 PM EDT * Appointed David-Alexandre Gros, M.D. Senior VP and chief business officer to serve as principal financial officer Read More >> Related Stocks: Alnylam Pharmaceuticals